Member Info for HedgeHogarth

My apologies - meant to post on AVCT.

Bring on the weekend - the RNS today provides some great news for the media to get interested in and spread the word.

I bet you at least 2 papers / magazines will be tipping this stock over the weekend

Just hoping this drops below 130p so i can top up before Monday morning ...

Bring on the weekend - the RNS today provides some great news for the media to get interested in and spread the word.

I bet you at least 2 papers / magazines will be tipping this stock over the weekend

Just hoping this drops below 130p so i can top up before Monday morning ...

AVCT was pretty resilient yesterday vs its peers. Hoping for a better day today and some renewed buying back I go this potential goldmine

Worzel - the debt is old news. Do you not think DBAY will have had confidence in achieving success here. Investors at 12p, 13p etc would also have been comfortable with debt position.

Check out the MCAP at this price and the debt is absolutely priced in to this stock.

The share price reflects the strength this company has in testing for COVID-19. This is not going to change in a hurry...
Why?
1 - Today's RNS
2 - The BBC's reporting of the new Rocke product. The NCT product remains the biggest play in town. I quote,

"The swab tests currently being carried out in the UK determine whether someone has the virus at the time of the test.

These will remain the core part of the government's test, track and trace strategy for containing the spread of the virus.

Wincanton results today - probably gives a good indication of how ESL may have been trading. No further mention of any interest in ESL - that could mean anything!

Cutting to the chase - there 2019/20 result was in line with guidance. They did see an increases in business at the start of the lockdown, but that has settled down. (It states that the contracts with grocers meant thy upside was limited)

Seem to be a lot of uncertaintly for this financial year - and less of an indication of how ESL will fair:
"It is too early to fully assess the financial implications of the COVID-19 crisis on the Group's business and there remains considerable uncertainty regarding the levels of demand and business interruption for the remainder of the year. Group revenues in April have been c.15% below the comparable period last year, but with significant variations across our different businesses and segments. The profit impact of volume shortfall is also varied according to contract types, particularly between open and closed book contracts, but as a whole the Group has seen a negative impact to its profitability in the financial year to date."

Tree shake in the US? 2+

With a low MCAP and resistance around 6p this is starting to look interesting. I am expect the news in the not too distant future will suggest signifcant underlying improvements to the business and as it already been well doumented, they will have faired relatively well through the CoronaVirus lockdow - with new opportunities coming their way.

The derampers will continue to scaremonger - but just look at MTFB and what can happen in a few minutes/hours/days.

Following Governanc guidance to employers to start preparig the way for peole to go back to work - i expect the private sector to invest in millions of tests - especially if they ca be procurd at a low unit cost. Social distancing in may environments is simply not achieveable in reality - so testing maybe the only solution.

This will not just be a UK thing - it wll be a world wide trend.

Could really increase the market opportunity for AVCT and otther Pharmas with a testing product

For me it's irrelevent - if the two listing trade consistently at a different value. If one goes up or down, I would expect the other to follow. I am expecting a blue day for TILS

No real change in situation from RNS other that a lack or progress. However, a six month extention nicely offsets this short term disappointment.

Share price IMO will continue to bounce about at curre t level. Given all what has come before, of you can hold on I expect there are better times ahead rather than bailing at a low price following underhand tactics

@ogm4. I do hope you mean £3.20!

For those a little confused about the different sorts of testing: I found this article really ckear and coherent. For me, this suggests that rich, developed nations will maintain commitment to the tests that NCYT produce...

https://www.newscientist.com/article/2238477-how-does-coronavirus-testing-work-and-will-we-have-a-home-test-soon/

I see that HFD will report finals on 2nd June.

Should holders expect any update ahead of that?

Assumig ESL may be eligible for signifcant loan from the Government as part of the COVID-19 support? Surely this could play a key role, in their funding equation...

https://www.gov.uk/guidance/apply-for-the-coronavirus-large-business-interruption-loan-scheme

Patent filing shared this afternoon through RNS

Hoping to add in the ninties today (or lower if i can :-)
Starting to look like we may see a lossening of policy on the Retail sector and freedom of movemnet. This will mean extra footfall and Halfords are already in a great position tomanage it having traded through the peak . For me, this is a short, medium and long term winner. (but more than happy to see it dip today to get some in the eighties)

That's 288k x 26 weeks x £8 = c£60m

Great to see NCYT able to commit to further signifcant contracts. Having had issues with dodgy tests alreasy, looks like Boris is keen to back quality here.

HFD has had a good run in April - so not sure i would say the trading has gone completely under the radar.

However, it was almost certainly oversold initially in line with overall sentiment in the Retail sector. I am expecting a srong trading update and future prospects do look good - whenever the lockdown eases just think of all those cars that will need some TLC after being left abandoned for so long!